Clinical Trial Update: Optimising Renal Outcome in Myeloma Renal Failure [Phase 2]

View source ↗

Summary

Phase 2 trial update on optimizing renal outcome in myeloma-related kidney failure.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Chronic Kidney Disease
• Multiple Myeloma

Snippet

Sponsor: Oxford University Hospitals NHS Trust | Conditions: Multiple Myeloma, Chronic Kidney Disease | Phase 2 | Status: COMPLETED | Results posted: 2022-01-27